Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;143(8):1598-1601.e10.
doi: 10.1016/j.jid.2023.02.010. Epub 2023 Mar 3.

Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies

Affiliations

Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies

Jake R Saklatvala et al. J Invest Dermatol. 2023 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustration of regression approach used to assess candidate phenotype diagnostic minPPV (IVW estimate). UK Biobank self-reported psoriasis effect size (y-axis) plot against Tsoi et al. specialist-diagnosed cohort effect size (x-axis) for 35 independent psoriasis risk SNVs. Red line is IVW estimated slope, with the shaded area indicating a 95% CI. CI, confidence interval; IVW, inverse variance–weighted; minPPV, lower bound of positive predictive value for psoriasis phenotype (i.e., IVW regression slope).
Supplementary Figure S1
Supplementary Figure S1
Simulations to characterize the impact of psoriasis case dilution on observed effect sizes. IVW estimates for each simulated PPV (1,000 simulations at each case dilution). Boxplots indicate the median and lower and upper quartiles of the simulations, with whiskers indicating 5th and 95th percentile and outliers shown as blue circles. Red line indicates theoretical linear dilution where IVW estimate corresponds to PPV. IVW, inverse variance–weighted; PPV, positive predictive value.
Supplementary Figure S2
Supplementary Figure S2
IVW slope estimate by number of cases across all candidate UK Biobank phenotypes. IVW slope estimate plot against the number of cases for each of the UK Biobank psoriasis definitions in Supplementary Table S2. IVW, inverse variance–weighted.
Supplementary Figure S3
Supplementary Figure S3
Power to detect novel psoriasis-associated risk factors for top-performing candidate psoriasis definitions. Comparison of phenotype IVW estimate (minPPV) and statistical power to detect novel psoriasis-associated risk factors under various scenarios for selected candidate psoriasis definitions that score highly on both measures. Y-axis: estimated statistical power; x-axis: IVW estimate of candidate psoriasis definition; left column: common risk factor (frequency 0.3); right column: rare risk factor (frequency 0.05); top row: weak risk factor (odds ratio 1.1); bottom row: strong risk factor (odds ratio 1.25). Candidate phenotype abbreviations are described in Table 1. IVW, inverse variance–weighted; minPPV, lower bound for the positive predictive value.
Supplementary Figure S4
Supplementary Figure S4
Comparison of candidate psoriasis definition IVW using selected and unselected controls. IVW slope estimates for UK Biobank psoriasis definitions with selected controls (Supplementary Table S2) plot against IVW slope estimate for equivalent UK Biobank psoriasis definitions with unselected controls (Supplementary Table S3). Red line (x = y) represents equality. IVW, inverse variance–weighted.
Supplementary Figure S5
Supplementary Figure S5
Comparison of risk allele frequencies between UK Biobank psoriasis controls (N = 141,279) and Tsoi et al. (2017) meta-analysis controls (N = 20,154). Risk allele frequency in UK Biobank psoriasis controls (y-axis) plotted against risk allele frequency in Tsoi et al. (2017) psoriasis controls, for SNVs in Supplementary Table S5 and HLA locus lead SNV (rs12189871).

References

    1. Boutin T.S., Charteris D.G., Chandra A., Campbell S., Hayward C., Campbell A., et al. Insights into the genetic basis of retinal detachment. Hum Mol Genet. 2020;29:689–702. - PMC - PubMed
    1. Bycroft C., Freeman C., Petkova D., Band G., Elliott L.T., Sharp K., et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–209. - PMC - PubMed
    1. Cai N., Revez J.A., Adams M.J., Andlauer T.F.M., Breen G., Byrne E.M., et al. Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nat Genet. 2020;52:437–447. - PMC - PubMed
    1. Han Y., Jia Q., Jahani P.S., Hurrell B.P., Pan C., Huang P., et al. Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma. Nat Commun. 2020;11:1776. - PMC - PubMed
    1. Mitchell B.L., Saklatvala J.R., Dand N., Hagenbeek F.A., Li X., Min J.L., et al. Genome-wide association meta-analysis identifies 29 new acne susceptibility loci. Nat Commun. 2022;13:702. - PMC - PubMed

Supplementary References

    1. Bycroft C., Freeman C., Petkova D., Band G., Elliott L.T., Sharp K., et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–209. - PMC - PubMed
    1. Chang C.C., Chow C.C., Tellier L.C., Vattikuti S., Purcell S.M., Lee J.J. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:7. - PMC - PubMed
    1. Howie B., Marchini J., Stephens M. Genotype imputation with thousands of genomes. G3(Bethesda) 2011;1:457–470. - PMC - PubMed
    1. Howie B.N., Donnelly P., Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5 - PMC - PubMed
    1. Machiela M.J., Chanock S.J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555–3557. - PMC - PubMed

Publication types